Skip to main content

Table 1 Baseline description and parameters of GBM datasets

From: DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients

Datasets

DKFZ (%)

EORTC/NCIC & LN-Pilot (%)

Nordic (%)

TCGA (%)

P-Value

N

214 (100)

177 (100)

105 (100)

99 (100)

 

Sex

    

0.1994

Female

101 (47)

66 (37)

40 (38)

42 (42)

 

Male

113 (53)

111 (63)

65 (62)

57 (58)

 

Patient age [years]

    

 < 0.0001

Min

29

27

60

33

 

Max

86

70

83

85

 

Mean, SD

60.34 ± 11.25

54.35 ± 8.98

70.82 ± 4.66

61.95 ± 10.64

 

DNAm age [years]

    

0.0001

Min

40.02

39.56

57.90

30.11

 

Max

174.01

167.42

180.10

186.71

 

Mean, SD

94.65 ± 22.58

94.13 ± 26.13

107.75 ± 25.17

98.71 ± 27.72

 

Age Acc [years]

    

0.1737

Min

− 13.45

− 9.50

− 7.19

− 14.89

 

Max

135.01

104.14

108.49

120.71

 

Mean (SD)

34.31 ± 21.25

39.78 ± 24.71

36.93 ± 25.09

36.76 ± 26.67

 

GBM subgroup

    

0.0141

GBM_MES

48 (22)

66 (37)

43 (41)

31 (31)

 

GBM_RTK_I

51 (24)

30 (17)

20 (19)

19 (19)

 

GBM_RTK_II

115 (54)

81 (46)

42 (40)

49 (49)

 

MGMT-STP27

    

0.4871

U

100 (47)

91 (51)

55 (52)

55 (56)

 

M

114 (53)

86 (49)

50 (48)

44 (44)

 

MGMT score

    

0.3412

Min

− 5.58

− 10.48

− 4.09

− 11.68

 

Max

6.98

7.35

8.16

6.34

 

Mean, SD

0.62 ± 3.59

0.22 ± 3.38

0.32 ± 3.31

− 0.23 ± 3.85

 

HM purity

    

0.6177

Min

0.31

0.42

0.42

0.39

 

Max

0.99

0.95

0.98

0.98

 

Mean, SD

0.73 ± 0.14

0.74 ± 0.14

0.75 ± 0.14

0.75 ± 0.14

 

Global HM entropy

    

0.9938

Min

0.45

0.47

0.47

0.49

 

Max

0.64

0.64

0.62

0.63

 

Mean, SD

0.55 ± 0.03

0.55 ± 0.03

0.55 ± 0.03

0.55 ± 0.03

 

HME Prom CpG:

    

0.2526

Min

0.27

0.29

0.29

0.28

 

Max

0.48

0.47

0.45

0.41

 

Mean, SD

0.36 ± 0.03

0.36 ± 0.03

0.36 ± 0.03

0.36 ± 0.03

 
  1. Description of datasets used in the analyses that were restricted to IDHwt GBM WHO grade 4, 2021, and corresponding parameters determined in this study. Significant differences between the datasets were observed for patient age and DNA methylation age of GBM (DNAm age), and GBM subtypes.
  2. Age Acc, DNAm age acceleration; GBM subgroup, methylation-based classification into mesenchymal (MES), RTK I and RTK II; Global HM entropy, human methylation based entropy of all genomic regions; HME Prom CpG, human methylation based entropy in promoter CpG islands; HM purity, human methylation based determination of sample purity; MGMT promoter methylation status, unmethylated U, methylated M, classified by MGMT-STP27 procedure; MGMT score, calculated with MGMT-STP27; SD, standard deviation.